Aligos Therapeutics Inc (ALGS)
0.7853
-0.01
(-1.29%)
USD |
NASDAQ |
Apr 18, 16:00
0.7853
0.00 (0.00%)
After-Hours: 20:00
Aligos Therapeutics Total Liabilities (Quarterly): 59.45M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 59.45M |
| September 30, 2023 | 31.03M |
| June 30, 2023 | 36.50M |
| March 31, 2023 | 36.99M |
| December 31, 2022 | 42.79M |
| September 30, 2022 | 42.06M |
| June 30, 2022 | 45.54M |
| March 31, 2022 | 57.58M |
| Date | Value |
|---|---|
| December 31, 2021 | 50.64M |
| September 30, 2021 | 46.06M |
| June 30, 2021 | 42.99M |
| March 31, 2021 | 39.32M |
| December 31, 2020 | 45.26M |
| September 30, 2020 | 228.85M |
| June 30, 2020 | 26.72M |
| December 31, 2019 | 211.41M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.72M
Minimum
Jun 2020
228.85M
Maximum
Sep 2020
65.20M
Average
44.13M
Median
Total Liabilities (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 397.95M |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 151.53M |
| Shareholders Equity (Quarterly) | 92.08M |
| Current Ratio | 5.902 |